Purpose Despite advances in personalizing the efficacy of cancer therapy, our ability to
identify patients at risk of severe treatment side effects and provide individualized supportive …

Background: This review aimed to evaluate the efficacy of oral cryotherapy in the prevention
of chemotherapy-induced oral mucositis using meta-analysis and trial sequential analysis …

As advances in cancer therapies have improved cancer-related survival, novel therapeutics
have also introduced a variety of dermatologic toxicities, and an increased number of …

Oral mucositis (OM) is a frequent complication of stem cell transplantation-associated toxicity
in haematological malignancies, contributing to mortality. Therapy still remains mainly …

The aim of the present study was to analyze the relationship of OM with possible risk factors
such as oral health condition, immunological status and IL-1β profile in patients submitted to …

Oral mukozit, kemoterapi ve/veya radyoterapiyi takiben oral mukoza bütünlüğünün
bozulmasıyla ortaya çıkmaktadır. Özellikle baş-boyun bölgesine uygulanan radyoterapi …

Oral mucositis is a painful and distressing complication of chemotherapy‐induced toxicity in
cancer patients that can develop early during the treatment regimen. Previous studies have …

Introduction New agents are introduced each day to be used in the prevention and treatment
of mucositis in cancer treatment. One of those agents is the Ankaferd hemostat. Ankaferd …

Bu çalışma hematolojik kanseri olan hastalarda kemoterapiye bağlı gelişenoral mukozitin
iştah ve beslenme durumuna etkisini incelemek amacıyla tanımlayıcı vekorelasyonel olarak …

Purpose Oral cryotherapy is an effective method to prevent oral mucositis (OM) induced by
chemotherapeutic agents, such as melphalan (Mel). However, there is limited data about …